{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:51:31Z","timestamp":1772164291899,"version":"3.50.1"},"reference-count":28,"publisher":"American Association for Cancer Research (AACR)","issue":"24","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ataxia telangiectasia mutated (ATM) kinase plays a crucial role in the cellular response to DNA damage and in radiation resistance. Although much effort has focused on the relationship between ATM and other nuclear signal transducers, little is known about interactions between ATM and mitogenic signaling pathways. In this study, we show a novel relationship between ATM kinase and extracellular signal-regulated kinase 1\/2 (ERK1\/2), a key mitogenic stimulator. Activation of ATM by radiation down-regulates phospho-ERK1\/2 and its downstream signaling via increased expression of mitogen-activated protein kinase phosphatase MKP-1 in both cell culture and tumor models. This dephosphorylation of ERK1\/2 is independent of epidermal growth factor receptor (EGFR) activity and is associated with radioresistance. These findings show a new function for ATM in the control of mitogenic pathways affecting cell signaling and emphasize the key role of ATM in coordinating the cellular response to DNA damage. (Cancer Res 2006; 66(24): 11554-9)<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-1935","type":"journal-article","created":{"date-parts":[[2006,12,18]],"date-time":"2006-12-18T12:57:56Z","timestamp":1166446676000},"page":"11554-11559","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Ataxia Telangiectasia Mutated Down-regulates Phospho-Extracellular Signal-Regulated Kinase 1\/2 via Activation of MKP-1 in Response to Radiation"],"prefix":"10.1158","volume":"66","author":[{"given":"Mukesh K.","family":"Nyati","sequence":"first","affiliation":[{"name":"1Radiation Oncology, Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix Y.","family":"Feng","sequence":"additional","affiliation":[{"name":"1Radiation Oncology, Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Maheshwari","sequence":"additional","affiliation":[{"name":"1Radiation Oncology, Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sooryanarayana","family":"Varambally","sequence":"additional","affiliation":[{"name":"2Pathology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven P.","family":"Zielske","sequence":"additional","affiliation":[{"name":"1Radiation Oncology, Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aarif","family":"Ahsan","sequence":"additional","affiliation":[{"name":"1Radiation Oncology, Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick Y.","family":"Chun","sequence":"additional","affiliation":[{"name":"1Radiation Oncology, Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay A.","family":"Arora","sequence":"additional","affiliation":[{"name":"1Radiation Oncology, Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary A.","family":"Davis","sequence":"additional","affiliation":[{"name":"1Radiation Oncology, Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mira","family":"Jung","sequence":"additional","affiliation":[{"name":"4Department of Radiation Medicine, Georgetown University Medical School, Washington, District of Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Ljungman","sequence":"additional","affiliation":[{"name":"1Radiation Oncology, Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine E.","family":"Canman","sequence":"additional","affiliation":[{"name":"3Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arul M.","family":"Chinnaiyan","sequence":"additional","affiliation":[{"name":"2Pathology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore S.","family":"Lawrence","sequence":"additional","affiliation":[{"name":"1Radiation Oncology, Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2006,12,18]]},"reference":[{"key":"2022061622110693700_B1","doi-asserted-by":"crossref","unstructured":"Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer\u20082003; 3: 155\u201368.","DOI":"10.1038\/nrc1011"},{"key":"2022061622110693700_B2","doi-asserted-by":"crossref","unstructured":"Brunet A, Roux D, Lenormand P, Dowd S, Keyse S, Pouyssegur J. Nuclear translocation of p42\/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J\u20081999; 18: 664\u201374.","DOI":"10.1093\/emboj\/18.3.664"},{"key":"2022061622110693700_B3","doi-asserted-by":"crossref","unstructured":"Cobb MH, Boulton TG, Robbins DJ. Extracellular signal-regulated kinases: ERKs in progress. Cell Regul\u20081991; 2: 965\u201378.","DOI":"10.1091\/mbc.2.12.965"},{"key":"2022061622110693700_B4","doi-asserted-by":"crossref","unstructured":"Schmidt-Ullrich RK, Mikkelsen RB, Dent P, et al. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene\u20081997; 15: 1191\u20137.","DOI":"10.1038\/sj.onc.1201275"},{"key":"2022061622110693700_B5","doi-asserted-by":"crossref","unstructured":"Keyse SM. Protein phosphatases and the regulation of MAP kinase activity. Semin Cell Dev Biol\u20081998; 9: 143\u201352.","DOI":"10.1006\/scdb.1997.0219"},{"key":"2022061622110693700_B6","doi-asserted-by":"crossref","unstructured":"Keyse SM, Emslie EA. Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature\u20081992; 359: 644\u20137.","DOI":"10.1038\/359644a0"},{"key":"2022061622110693700_B7","doi-asserted-by":"crossref","unstructured":"Lee SA, Dritschilo A, Jung M. Role of ATM in oxidative stress-mediated c-Jun phosphorylation in response to ionizing radiation and CdCl2. J Biol Chem\u20082001; 276: 11783\u201390.","DOI":"10.1074\/jbc.M004517200"},{"key":"2022061622110693700_B8","doi-asserted-by":"crossref","unstructured":"Chun PY, Feng FY, Scheurer AM, Davis MA, Lawrence TS, Nyati MK. Synergistic effects of gemcitabine and gefitinib in the treatment of head and neck carcinoma. Cancer Res\u20082006; 66: 981\u20138.","DOI":"10.1158\/0008-5472.CAN-05-2665"},{"key":"2022061622110693700_B9","doi-asserted-by":"crossref","unstructured":"Nyati MK, Maheshwari D, Hanasoge S, et al. Radiosensitization by pan ErbB inhibitor CI-1033 in vitro and in vivo. Clin Cancer Res\u20082004; 10: 691\u2013700.","DOI":"10.1158\/1078-0432.CCR-1041-03"},{"key":"2022061622110693700_B10","doi-asserted-by":"crossref","unstructured":"Fertil B, Dertinger H, Courdi A, Malaise EP. Mean inactivation dose: a useful concept for intercomparison of human cell survival curves. Radiat Res\u20081984; 99: 73\u201384.","DOI":"10.2307\/3576448"},{"key":"2022061622110693700_B11","doi-asserted-by":"crossref","unstructured":"Zufferey R, Dull T, Mandel RJ, et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol\u20081998; 72: 9873\u201380.","DOI":"10.1128\/JVI.72.12.9873-9880.1998"},{"key":"2022061622110693700_B12","doi-asserted-by":"crossref","unstructured":"Feng FY, Varambally S, Tomlins SA, et al. The role of EGFR degradation in gemcitabine-mediated cytotoxicity. Oncogene Epub 2006, Dec 4.","DOI":"10.1038\/sj.onc.1210129"},{"key":"2022061622110693700_B13","doi-asserted-by":"crossref","unstructured":"Wu W, Pew T, Zou M, Pang D, Conzen SD. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival. J Biol Chem\u20082005; 280: 4117\u201324.","DOI":"10.1074\/jbc.M411200200"},{"key":"2022061622110693700_B14","doi-asserted-by":"crossref","unstructured":"Kar S, Adachi T, Carr BI. EGFR-independent activation of ERK1\/2 mediates growth inhibition by a PTPase antagonizing K-vitamin analog. J Cell Physiol\u20082002; 190: 356\u201364.","DOI":"10.1002\/jcp.10063"},{"key":"2022061622110693700_B15","doi-asserted-by":"crossref","unstructured":"Sun H, Charles CH, Lau LF, Tonks NK. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell\u20081993; 75: 487\u201393.","DOI":"10.1016\/0092-8674(93)90383-2"},{"key":"2022061622110693700_B16","doi-asserted-by":"crossref","unstructured":"Larner JM, Lee H, Hamlin JL. Radiation effects on DNA synthesis in a defined chromosomal replicon. Mol Cell Biol\u20081994; 14: 1901\u20138.","DOI":"10.1128\/MCB.14.3.1901"},{"key":"2022061622110693700_B17","doi-asserted-by":"crossref","unstructured":"Falck J, Mailand N, Syljuasen RG, Bartek J, Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature\u20082001; 410: 842\u20137.","DOI":"10.1038\/35071124"},{"key":"2022061622110693700_B18","doi-asserted-by":"crossref","unstructured":"Ziv Y, Bar-Shira A, Pecker I, et al. Recombinant ATM protein complements the cellular A-T phenotype. Oncogene\u20081997; 15: 159\u201367.","DOI":"10.1038\/sj.onc.1201319"},{"key":"2022061622110693700_B19","unstructured":"Alessi DR, Smythe C, Keyse SM. The human CL100 gene encodes a Tyr\/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts. Oncogene\u20081993; 8: 2015\u201320."},{"key":"2022061622110693700_B20","doi-asserted-by":"crossref","unstructured":"Slack DN, Seternes OM, Gabrielsen M, Keyse SM. Distinct binding determinants for ERK2\/p38\u03b1 and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1. J Biol Chem\u20082001; 276: 16491\u2013500.","DOI":"10.1074\/jbc.M010966200"},{"key":"2022061622110693700_B21","doi-asserted-by":"crossref","unstructured":"Lim DS, Kim ST, Xu B, et al. ATM phosphorylates p95\/nbs1 in an S-phase checkpoint pathway. Nature\u20082000; 404: 613\u20137.","DOI":"10.1038\/35007091"},{"key":"2022061622110693700_B22","doi-asserted-by":"crossref","unstructured":"Zhao S, Weng YC, Yuan SS, et al. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature\u20082000; 405: 473\u20137.","DOI":"10.1038\/35013083"},{"key":"2022061622110693700_B23","doi-asserted-by":"crossref","unstructured":"Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science\u20081995; 270: 1326\u201331.","DOI":"10.1126\/science.270.5240.1326"},{"key":"2022061622110693700_B24","doi-asserted-by":"crossref","unstructured":"Huang HS, Nagane M, Klingbeil CK, et al. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J Biol Chem\u20081997; 272: 2927\u201335.","DOI":"10.1074\/jbc.272.5.2927"},{"key":"2022061622110693700_B25","doi-asserted-by":"crossref","unstructured":"Bar-Shira A, Rashi-Elkeles S, Zlochover L, et al. ATM-dependent activation of the gene encoding MAP kinase phosphatase 5 by radiomimetic DNA damage. Oncogene\u20082002; 21: 849\u201355.","DOI":"10.1038\/sj.onc.1205127"},{"key":"2022061622110693700_B26","doi-asserted-by":"crossref","unstructured":"Sebolt-Leopold JS, Dudley DT, Herrera R, et al. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat Med\u20081999; 5: 810\u20136.","DOI":"10.1038\/10533"},{"key":"2022061622110693700_B27","doi-asserted-by":"crossref","unstructured":"Zhang N, Chen P, Khanna KK, et al. Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype. Proc Natl Acad Sci U S A\u20081997; 94: 8021\u20136.","DOI":"10.1073\/pnas.94.15.8021"},{"key":"2022061622110693700_B28","unstructured":"Xu B, O'Donnell AH, Kim ST, Kastan MB. Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation. Cancer Res\u20082002; 62: 4588\u201391."}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/24\/11554\/2557826\/11554.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/24\/11554\/2557826\/11554.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T19:53:00Z","timestamp":1655409180000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/24\/11554\/526613\/Ataxia-Telangiectasia-Mutated-Down-regulates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,15]]},"references-count":28,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2006,12,18]]},"published-print":{"date-parts":[[2006,12,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-1935","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22365662.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22365662","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6494810","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6494810.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,15]]}}}